Summer Offer: UBS vs. Guggenheim vs. Rothschild (RX)

Was hoping people could lend some insight into these three firms. I would be looking to do M&A at UBS/Gugg or RX at Rothschild. Specifically, what are the exit ops like from the three places, I want to eventually do PE and want to know which would give me the best chance to end up at a good firm. (All NYC)

WSO Elite Modeling Package

  • 6 courses to mastery: Excel, Financial Statement, LBO, M&A, Valuation and DCF
  • Elite instructors from top BB investment banks and private equity megafunds
  • Includes Company DB + Video Library Access (1 year)

Comments (26)

May 8, 2018 - 1:32pm

Rothschild RX no question. Although i could see some people taking Guggenheim (on the rise, M&A). The exits from Guggeneheim were good but for some reason their analaysts class have been huge these past years.

Rothschild RX are top of the street (aside from HL/PJT) and while many of you exits will be in distressed PE/HF I have heard that they still can land into top MM/MF due to the pedigree.

May 8, 2018 - 2:15pm

Thanks for the input, I am mostly in between Guggenheim and Rothschild, but am having a hard time judging the differences in exits becuase of Guggenheim being big is the difference between the exits between the two in the PE space? and I was under the impression that analyst size has grown becuase the firm has grown so much over the past few years

May 8, 2018 - 5:27pm

Lol so much MS.

Guggenheim is def a good firm but I'd personally take rothschild rx. Even if they lost their co-heads (which i understand of course is not good) they're still doing well on league tables. For Guggenheim their analyst class this past summer was 60. Thats larger than both Evercore/Lazard the largest EBs. I believe their PE exits this year were solid but with this much increase in headcount? Im not sure if your average Guggenheim analyst exit will be that great. Sure a couple may land into top MM/MF but its really about which group (i.e. healthcare/TMT)you land into and I'd personally would not want to deal with that.

As for specific exits im sure a good linkedin scan or any of your networking connections in rothschild or gugg will tell you better

Learn More

300+ video lessons across 6 modeling courses taught by elite practitioners at the top investment banks and private equity funds -- Excel Modeling -- Financial Statement Modeling -- M&A Modeling -- LBO Modeling -- DCF and Valuation Modeling -- ALL INCLUDED + 2 Huge Bonuses.

Learn more
May 8, 2018 - 6:35pm

That is what I have heard as the consensus that an analyst class of 40+ will dilute exits? I was under the impression that it won't make much of a difference because the name of your bank only gets you looked at, after that it is up to you to get the offer, so the number of analysts shouldn't really affect any one person's experience. With the logic being that if someone was good enough to get a PE job in an analyst class size of 15, they would be good enough to get one in an analyst class size of 40. I could be missing something though

May 8, 2018 - 7:22pm

Exactly as you and jmcbanker said. If you are a good analyst you will be put on the mega deals the firm is known for and get the best shot at PE recruiting. Even without Gugg in the picture, how can someone say that Rothschild Rx will not suffer a huge reputation drop when not one but both of their group heads have left the firm. I would think these guys know more about where the firm's U.S presence is heading than us

Best Response
May 8, 2018 - 6:34pm

Go with Guggenheim if you want PE. Here's why: you need to be a top analyst at any firm (yes, that includes Evercore, Lazard, etc.) to get good exits. There's this huge misconception on WSO that if you get a top group at a top BB or EB, you're somehow set for PE recruiting. What matters so so so much more is your actual skill level.

May 9, 2018 - 11:55am

Tempore temporibus natus neque voluptas ut consequatur. Inventore quaerat eum voluptatibus delectus. Nobis ut distinctio in voluptatem temporibus sapiente.

A unde enim ab. Sed sit mollitia exercitationem sed. Et reprehenderit quisquam deserunt rerum nulla et. Est nihil tempore ad quo ducimus. Omnis aut vel ratione unde non eum architecto. Blanditiis exercitationem unde ut quos nesciunt consequatur in.

Veritatis sunt nihil in omnis. Voluptas distinctio sit molestias et. Qui excepturi asperiores eos non. Sit quia ratione nostrum.

Start Discussion

Total Avg Compensation

October 2021 Investment Banking

  • Director/MD (10) $853
  • Vice President (39) $363
  • Associates (229) $233
  • 2nd Year Analyst (139) $155
  • 3rd+ Year Analyst (32) $149
  • Intern/Summer Associate (104) $143
  • 1st Year Analyst (504) $135
  • Intern/Summer Analyst (387) $83